OCI NV (OCI.AS) Stock Fundamental Analysis
AMS:OCI - Euronext Amsterdam - NL0010558797 - Common Stock - Currency: EUR
We assign a fundamental rating of 3 out of 10 to OCI. OCI was compared to 67 industry peers in the Chemicals industry. Both the profitability and financial health of OCI have multiple concerns. OCI has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
OCI had negative earnings in the past year.
OCI had a positive operating cash flow in the past year.
In multiple years OCI reported negative net income over the last 5 years.
OCI had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of OCI (-5.28%) is worse than 70.15% of its industry peers.
OCI has a Return On Equity of -51.53%. This is amonst the worse of the industry: OCI underperforms 83.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.28% | ||
| ROE | -51.53% | ||
| ROIC | N/A |
ROA(3y)41.1%
ROA(5y)25.43%
ROE(3y)77.65%
ROE(5y)49.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
OCI's Profit Margin has improved in the last couple of years.
The Gross Margin of OCI (2.23%) is worse than 86.57% of its industry peers.
OCI's Gross Margin has declined in the last couple of years.
OCI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 2.23% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y283.84%
PM growth 5YN/A
GM growth 3Y-81.68%
GM growth 5Y-54.61%
2. Health
2.1 Basic Checks
OCI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OCI has about the same amount of shares outstanding.
The number of shares outstanding for OCI has been increased compared to 5 years ago.
The debt/assets ratio for OCI has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.20, we must say that OCI is in the distress zone and has some risk of bankruptcy.
OCI has a worse Altman-Z score (0.20) than 83.58% of its industry peers.
The Debt to FCF ratio of OCI is 44.52, which is on the high side as it means it would take OCI, 44.52 years of fcf income to pay off all of its debts.
OCI has a Debt to FCF ratio of 44.52. This is comparable to the rest of the industry: OCI outperforms 46.27% of its industry peers.
A Debt/Equity ratio of 2.03 is on the high side and indicates that OCI has dependencies on debt financing.
OCI has a worse Debt to Equity ratio (2.03) than 89.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.03 | ||
| Debt/FCF | 44.53 | ||
| Altman-Z | 0.2 |
ROIC/WACCN/A
WACC5.96%
2.3 Liquidity
OCI has a Current Ratio of 1.39. This is a normal value and indicates that OCI is financially healthy and should not expect problems in meeting its short term obligations.
OCI's Current ratio of 1.39 is on the low side compared to the rest of the industry. OCI is outperformed by 65.67% of its industry peers.
OCI has a Quick Ratio of 1.37. This is a normal value and indicates that OCI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.37, OCI is in the better half of the industry, outperforming 73.13% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.39 | ||
| Quick Ratio | 1.37 |
3. Growth
3.1 Past
OCI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -123.19%.
Measured over the past years, OCI shows a very strong growth in Earnings Per Share. The EPS has been growing by 105.88% on average per year.
The Revenue for OCI has decreased by -58.51% in the past year. This is quite bad
Measured over the past years, OCI shows a very negative growth in Revenue. The Revenue has been decreasing by -20.30% on average per year.
EPS 1Y (TTM)-123.19%
EPS 3Y105.88%
EPS 5YN/A
EPS Q2Q%164.52%
Revenue 1Y (TTM)-58.51%
Revenue growth 3Y-46.36%
Revenue growth 5Y-20.3%
Sales Q2Q%-11.72%
3.2 Future
OCI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 71.49% yearly.
OCI is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -14.70% yearly.
EPS Next Y770.92%
EPS Next 2Y251.29%
EPS Next 3Y133.31%
EPS Next 5Y71.49%
Revenue Next Year-27.81%
Revenue Next 2Y-14.07%
Revenue Next 3Y-23.72%
Revenue Next 5Y-14.7%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for OCI. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 20.05, OCI is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of OCI is on the same level as its industry peers.
OCI is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.90, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 20.05 |
4.2 Price Multiples
OCI's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.88 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
OCI's earnings are expected to grow with 133.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y251.29%
EPS Next 3Y133.31%
5. Dividend
5.1 Amount
OCI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AMS:OCI (7/4/2025, 7:00:00 PM)
7.55
-0.07 (-0.92%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners32.13%
Inst Owner ChangeN/A
Ins Owners8.71%
Ins Owner ChangeN/A
Market Cap1.60B
Analysts75.38
Price Target11.3 (49.67%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend13.02
Dividend Growth(5Y)N/A
DP-36.26%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)486.8%
Min EPS beat(2)232.01%
Max EPS beat(2)741.58%
EPS beat(4)2
Avg EPS beat(4)85.49%
Min EPS beat(4)-492.57%
Max EPS beat(4)741.58%
EPS beat(8)3
Avg EPS beat(8)31.49%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)37.56%
Min Revenue beat(2)20.15%
Max Revenue beat(2)54.98%
Revenue beat(4)2
Avg Revenue beat(4)8.41%
Min Revenue beat(4)-23.05%
Max Revenue beat(4)54.98%
Revenue beat(8)5
Avg Revenue beat(8)21.58%
Revenue beat(12)9
Avg Revenue beat(12)32.19%
Revenue beat(16)12
Avg Revenue beat(16)36.43%
PT rev (1m)-19.45%
PT rev (3m)-30.73%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)151.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-24.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 20.05 | ||
| P/S | 0.41 | ||
| P/FCF | 34.88 | ||
| P/OCF | 3.4 | ||
| P/B | 2.04 | ||
| P/tB | 2.17 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.41
EYN/A
EPS(NY)0.38
Fwd EY4.99%
FCF(TTM)0.22
FCFY2.87%
OCF(TTM)2.22
OCFY29.41%
SpS18.28
BVpS3.7
TBVpS3.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.28% | ||
| ROE | -51.53% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 2.23% | ||
| FCFM | 1.18% |
ROA(3y)41.1%
ROA(5y)25.43%
ROE(3y)77.65%
ROE(5y)49.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y283.84%
PM growth 5YN/A
GM growth 3Y-81.68%
GM growth 5Y-54.61%
F-Score3
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.03 | ||
| Debt/FCF | 44.53 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | -4159.17% | ||
| Cap/Sales | 10.96% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.39 | ||
| Quick Ratio | 1.37 | ||
| Altman-Z | 0.2 |
F-Score3
WACC5.96%
ROIC/WACCN/A
Cap/Depr(3y)137.7%
Cap/Depr(5y)97.09%
Cap/Sales(3y)24.99%
Cap/Sales(5y)17.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-123.19%
EPS 3Y105.88%
EPS 5YN/A
EPS Q2Q%164.52%
EPS Next Y770.92%
EPS Next 2Y251.29%
EPS Next 3Y133.31%
EPS Next 5Y71.49%
Revenue 1Y (TTM)-58.51%
Revenue growth 3Y-46.36%
Revenue growth 5Y-20.3%
Sales Q2Q%-11.72%
Revenue Next Year-27.81%
Revenue Next 2Y-14.07%
Revenue Next 3Y-23.72%
Revenue Next 5Y-14.7%
EBIT growth 1Y-118.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year309.47%
EBIT Next 3Y-17.67%
EBIT Next 5Y-4.61%
FCF growth 1Y-95.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-71.4%
OCF growth 3Y-68.9%
OCF growth 5Y-27.39%